TCM Pharma ApS: Financial statements 2020
CVR: 39022508
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TCM Pharma ApS (CVR 39022508) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 66,690 and a net result of DKK -275,872 compared with DKK -113,842 the year before. Equity in the 2020 report amounted to DKK -348,103.
- Gross Profit
- DKK 66,690
- Profit/Loss
- DKK -275,872
- Equity
- DKK -348,103
- Total Assets
- DKK 1,081,909
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 67 t. | -276 t. | -348 t. | 0 |
| 2019 | - | -17 t. | -114 t. | -72 t. | - |
Official annual report
How creditworthy is TCM Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TCM Pharma ApS has published its annual report for 2019. Gross profit came to DKK -16,577, and the net result was DKK -113,842.
About TCM Pharma ApS
TCM Pharma ApS is a Danish company of the type Anpartsselskab based in Farsø, founded in 2017. The company is under bankruptcy. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Løgstørvej 80 ApS and S. Greenhouse ApS. The company is owned by A.T.L. Holding ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 223,313 and a net result of DKK 136,379 compared with DKK -163,358 the year before. Equity in the 2023 report amounted to DKK 53,353.